1. Introduction {#s0005}
===============

It is estimated that three to five million cases of severe influenza illness occur annually worldwide, resulting in 250,000--500,000 deaths [@b0005]. Identifying groups at risk for severe influenza disease is essential to prevention and control efforts.

World Health Organization (WHO) influenza vaccine policy recommendations aim to protect high-risk groups from severe disease. In a 2012 update, WHO recommended for the first time that one risk group, pregnant women, be prioritized over others [@b0010]. This was based on numerous factors, including reports of higher influenza disease risk in pregnant women, the possibility to protect young infants via placental antibody transfer, vaccine safety and effectiveness, and programmatic opportunities [@b0010].

The influenza disease risk posed to pregnant women has never been comprehensively addressed in a systematic review. We conducted a systematic review to quantify the association between pregnancy and severe influenza disease and to summarize the evidence for pregnancy as a risk factor for severe influenza disease.

2. Materials and methods {#s0010}
========================

All the methods outlined below were specified *a priori*.

2.1. Data sources and searches {#s0015}
------------------------------

We searched MEDLINE (since 1966; [Supplementary Table 1](#s0100){ref-type="sec"}), EMBASE (since 1980), CINAHL (since 1982), and the Cochrane Central Register of Controlled Trials (CENTRAL). We also searched reference lists of identified articles and review articles. We included relevant studies selected in our previous systematic review on risk factors for severe outcomes from influenza (search up to March 25, 2011 [@b0015]), and updated the search using the same search strategy through April 25, 2014 ([Fig. 1](#f0005){ref-type="fig"}).

2.2. Study selection {#s0020}
--------------------

Studies reporting on pregnancy as a risk factor for the following severe outcomes following influenza: community-acquired pneumonia, death from all causes or related to influenza, hospitalization from all causes or related to influenza, admission to an intensive care unit (ICU) related to influenza, and/or need for mechanical ventilatory support. Study designs included observational studies with a comparator arm of non-pregnant patients with evidence of influenza virus infection. Ecologic studies, also included, were defined as studies that collected data at a group rather than at an individual level, or in which numerators or denominators were imputed or estimated. Non-English language articles were excluded in the search update, based on the limited value demonstrated in the first search [@b0015].

Evidence for influenza virus infection was based on laboratory-confirmed influenza virus infection defined by at least one of the following: serology, viral culture, nucleic acid amplification testing, or antigen detection. Representation of non-laboratory defined evidence, such as influenza-like illness during known influenza circulation, although eligible for the review, was negligible (n = 3 studies, 2.1%). Studies on avian influenza A virus infection in humans were excluded.

2.3. Data extraction and quality assessment {#s0025}
-------------------------------------------

Two reviewers independently screened titles, abstracts and full text articles, extracted data using a standardized and pilot-tested database, and assessed risk of bias. Any disagreement between reviewers was resolved by consensus or arbitration by a third reviewer.

We used the Newcastle Ottawa Scale (NOS) to assess risk of bias for individual-level studies [@b0020]. With this scale, a maximum of 9 points was allocated in four domains: a maximum of 4 points for selection of study groups, 2 points for comparability of groups, and up to 3 points for ascertainment of exposure and outcomes. In order to evaluate publication bias, funnel-plots were made if ten or more studies had been included. The overall quality of evidence was assessed using the recently published GRADE framework for evidence about prognosis [@b0025].

2.4. Data synthesis and analysis {#s0030}
--------------------------------

We performed a meta-analyses using a random effects model in Review Manager 5.0 (Cochrane Collaboration) [@b0030] to obtain a summary estimate of the average effect with its 95% confidence interval (CI). Given the small number of non-cohort observational studies, we pooled all design types. Ecologic studies were only synthesized qualitatively.

To compare studies of similar design, we stratified the meta-analyses by type of population at the time of enrollment (community setting, hospitalized patients, and ICU patients). Heterogeneity was evaluated using χ^2^ and I^2^ statistics [@b0035]. We considered a χ^2^ of \<0.10 or an I^2^ statistic of \>50% to reflect significant heterogeneity that triggered additional *a priori* defined subgroup analysis: seasonal versus pandemic influenza, level of risk of bias as judged by the NOS, variable definitions of influenza virus infection, and variable influenza vaccine receipt.

Because the findings may vary depending on the definition of influenza, we planned to conduct a sensitivity analysis excluding all studies with lack of laboratory confirmation. When multiple comparator groups were available, the most appropriate was used, i.e. non-pregnant women of reproductive age was the preferred comparator, followed by non-pregnant women of any age and then all other patients including males. Because non-matching comparator groups may have biased the results of the primary analysis, we conducted a sensitivity analysis including only studies that used non-pregnant women of reproductive age as a comparator.

3. Results {#s0035}
==========

We screened an additional 17,013 records after duplicates were removed to update our previous search [@b0015] yielding an additional 89 publications meeting inclusion criteria in addition to the 63 publications identified from the previous search for a total of 152 included studies, 142 individual-level and 10 ecological studies ([Fig. 1](#f0005){ref-type="fig"}; [Table 1](#t0005){ref-type="table"}). Individual-level studies included 134 cohort and four cross-sectional, and four case control studies with data on a combined total of 310,597 patients ([Supplementary Tables 2--4](#s0100){ref-type="sec"}). The majority of studies were conducted in Europe (n = 49, 34.5%), followed by Asia (n = 31, 21.8%) and North America (n = 30, 21.1%). A total of 45 studies (31.7%) were conducted in middle-income countries while no studies were conducted in low-income countries (<http://data.worldbank.org/>).

3.1. Individual level studies {#s0040}
-----------------------------

All but six individual-level studies (n = 136, 95.8%) reported on pandemic influenza either alone or in combination with seasonal influenza. Of these, all but three studies reported on the 2009 influenza A (H1N1) pandemic (pH1N1). A total of 17 studies with 14,366 patients reported on seasonal influenza with 11 studies (64.7%) reporting on post-pandemic H1N1.

All studies enrolled participants that sought medical care. Twenty-four (16.9%) studies enrolled non-hospitalized patients (referred to as community setting below), including seven studies comprised entirely of patients seen at an emergency department, five studies that included patients from emergency departments and outpatient clinics, and 12 studies that did not report the setting in detail. Only three studies provided adjusted risk estimates for pregnancy as a risk factor for hospitalization while controlling for other co-morbidities, influenza vaccination status, and/or treatment with antivirals [@b0040], [@b0045], [@b0050]. A single study reported on other outcomes of interest while adjusting for age [@b0055], but we found no studies that adjusted for any of the other relevant co-morbidities. Furthermore, no attempt was made to measure severity of illness at the time of presentation.

Since there were few non-2009 pandemic studies, no subgroup analyses by type/subtype or pandemic versus seasonal was conducted. Subgroup analyses based on risk of bias was also not feasible given that the vast majority (n = 132, 92.3%) of studies were at some but not severe risk of bias (5--7 NOS points). The same was true for studies that defined influenza virus infection based on laboratory confirmation versus clinical criteria since only three studies (2.1%) lacked laboratory confirmation. Finally, influenza vaccination status and antiviral therapy were not routinely reported in the studies and thus were not analyzed.

### 3.1.1. All-cause mortality {#s0045}

A total of 94 studies reported on mortality. All but 11 studies (11.7%) included hospitalized patients, only. Pregnancy was not found to be associated with a higher risk (odds ratio (OR) 1.04, 95% confidence Interval (CI): 0.81--1.33) ([Fig. 2](#f0010){ref-type="fig"}). There was significant heterogeneity (I^2^ = 63%) which could not be explained on the basis of subgrouping by population at risk ((I^2^ = 50.1%, p = 0.14 for subgroup effect). The risk estimate for pregnancy associated mortality in the community setting was elevated but not significantly (OR 1.79, 95% CI 0.88--3.61) when compared to hospitalized patients. A total of 18 studies allowed for the use of non-pregnant women of reproductive age as the comparator for sensitivity analysis yielding a similar result (OR 1.02, 95% CI 0.57--1.84; I^2^ = 66%).

### 3.1.2. Hospital and ICU admission {#s0050}

Thirteen studies reported on the risk of hospitalization ([Fig. 3](#f0015){ref-type="fig"}). Due to a significant overlap in study populations between two studies [@b0060], [@b0065], the study with the smaller sample size was excluded [@b0065]. Four studies (30.8%) enrolled patients through the emergency department, three studies (23.1%) also included enrolled patients from outpatient clinics, and the enrollment setting was not described in detail in the remaining studies (n = 6, 46.2%).

The risk for hospital admission in pregnant women was significantly higher than for non-pregnant patients (OR 2.44, 95% CI 1.22--4.87; I^2^ = 95%). Only two studies could be included in the sensitivity analysis restricted to studies with non-pregnant women of reproductive age as the comparator showing a similar effect size (OR 3.28, 95% CI 0.52--20.6; I^2^ = 84%). A potential explanation for the high heterogeneity between these two studies was related to the inclusion criteria: while one study included patients presenting to the emergency department in Turkey [@b0070], the other study included a mix of patients from a hospital emergency department and from outpatient clinics in Canada [@b0040]. The three studies that reported risk estimates adjusted for other co-morbidities, all found slightly higher risks associated with pregnancy in the adjusted versus unadjusted analysis [@b0040], [@b0045], [@b0050].

ICU admission related to influenza was reported as an outcome in 47 studies ([Supplementary Fig. 1](#s0100){ref-type="sec"}). Only four studies (8.5%) included patients from a community setting, with two of these limited to patients presenting to an emergency department. No significant difference between pregnant and non-pregnant patients was found (OR 0.85, 95% CI 0.62--1.17; I^2^ = 81%), with an I^2^ of 0% in the subgroup of community-based studies. There was no significant subgroup effect (I^2^ = 0%, p = 0.45). A sensitivity analysis limited to the 10 studies that reported data on women of reproductive age as the comparator group found a significantly lower risk for ICU admission for pregnant women (OR 0.51, 95% CI 0.42--0.62; I^2^ = 17%) ([Supplementary Fig. 2](#s0100){ref-type="sec"}).

### 3.1.3. Other outcomes {#s0055}

Eight studies reported on pneumonia following influenza as an outcome ([Supplementary Fig. 3](#s0100){ref-type="sec"}) with only one study from a community setting. No significant differences were found (OR 1.80, 95% CI 0.72--4.49; I^2^ = 75%). There was no significant subgroup effect when stratified by type of population (I^2^ = 47.7%, p = 0.15). For the three studies used for the sensitivity analysis with women of reproductive age as the comparator, no association was found between pneumonia following influenza and pregnancy (OR 1.09, 95% CI 0.29--4.08; I^2^ = 84%).

There were a total of 26 studies reporting on receipt of mechanical ventilatory support among patients with evidence of influenza ([Supplementary Fig. 4](#s0100){ref-type="sec"}), with only one study from a community setting. No significant difference between pregnant and non-pregnant patients (OR 1.21, 95% CI 0.70--2.08) and no subgroup effect by type of population was found. Heterogeneity was significant with an I^2^ of 68%, with no statistical heterogeneity in the ICU subgroup. Among eight studies with data on women of reproductive age as comparators, the findings were similar, with no significant association (OR 0.82, 95% CI 0.40--1.67; I^2^ = 77%).

Twenty-one studies reported a composite outcome of ICU admission and/or all-cause mortality among patients with evidence of influenza, all conducted in a hospital-setting ([Supplementary Fig. 5](#s0100){ref-type="sec"}). No association was found between this composite outcome and pregnancy (OR 0.95, 95% CI 0.59--1.52; I^2^ = 84%). Among four studies with data on women of reproductive age as the comparator, no significant association was seen (OR 0.88, 95% CI 0.62--1.25; I^2^ = 0%).

3.2. Ecological studies {#s0060}
-----------------------

Ten studies reported group-level data on pregnancy as a risk factor for severe outcomes following influenza, all focused on the 2009 pH1N1 pandemic ([Table 1](#t0005){ref-type="table"}). Of the ecological studies reporting on mortality, 4 of 7 (57%) reported significantly higher mortality rates among pregnant women than among non-pregnant patients ([Table 1](#t0005){ref-type="table"}). All four studies that reported on hospitalization and two studies that reported on ICU-admission found a higher risk for pregnant women than for the comparator.

3.3. Risk of bias and grading the quality of evidence {#s0065}
-----------------------------------------------------

Individual-level studies achieved an average of 6 out of a maximum of 9 points on the Newcastle-Ottawa Scale (interquartile range 6--7, range 3--8) ([Supplementary Table 1](#s0100){ref-type="sec"}). There was no evidence of publication bias in Funnel plots (data not shown).

We identified several biases that may have overestimated risk estimates in ecological studies. For all ecological studies, the number of pregnant women was estimated rather than known. Also, the comparator group included both patients with and without influenza in 8/10 ecological studies (80%). Three ecological studies (30%) included outcomes occurring during the postpartum period. Two studies each (20%) relied on passive surveillance systems or were based on enhanced surveillance for at-risk populations. In one study, lab confirmation was restricted to high risk populations.

Applying the GRADE framework [@b0025], we downgraded the quality of evidence for all outcomes for risk of bias, as well as for inconsistency due to high heterogeneity in the meta-analysis or inconsistencies when comparing the finding in individual-level studies to ecological studies. Additionally, given the wide confidence intervals around the summary estimate that could not rule out patient-important differences, all outcomes other than hospitalization were downgraded further. Hospitalization was upgraded based on the large effect size observed. Therefore, all outcomes other than hospitalization (moderate level of evidence) were deemed to be based on a very low quality of evidence.

4. Discussion {#s0070}
=============

In our systematic review and meta-analysis, we found that pregnant women with influenza have a higher risk of hospitalizations than non-pregnant patients with influenza. Pregnant women with influenza virus infection did not have a greater likelihood of death or other severe outcomes than either the general population or non-pregnant women of reproductive age. These findings contrast with ecological studies which suggest that, in addition to the increase in hospitalization, there is a higher risk of death and ICU admission in pregnancy associated influenza disease. The quality of the evidence was found to be moderate for hospital admission and very low for all other outcomes. To our knowledge, this is the first comprehensive systematic review of outcomes of influenza in pregnancy.

The most unexpected result was for mortality, where the point estimate revealed a risk that is virtually the same when comparing pregnant to non-pregnant patients and the confidence intervals did not suggest a large possible effect size (OR 1.04 (95% CI 0.81--1.33). It remains uncertain whether this represents a true absence of association or whether it is a result of bias. Notably, no studies initiated follow-up before contact with the healthcare system. It is likely that people who present to a health care provider with influenza are a select group enriched for risk factors for a more severe clinical presentation, such as co-morbidities and possibly pregnancy. Consequently, our results may reflect pregnancy conferring no greater risk than the risk associated with conditions such as cardiorespiratory disease, obesity, or advanced age. This hypothesis is supported by the three studies that reported higher odds ratios when adjustments were made for other co-morbidities [@b0045], [@b0050], [@b0075].

An additional potential bias was that none of the community-based studies attempted to assess severity of illness at presentation. If health care providers perceived pregnancy as a particular risk for severe illness, they might have hospitalized pregnant women with less severe illness at presentation for precautionary reasons. This was particularly likely during the 2009 pH1N1 pandemic, when clinicians were warned that pregnant women had increased risk of severe influenza outcomes [@b0080], [@b0085], [@b0090]. To overcome these biases, an ideal study would enroll participants -- pregnant and non-pregnant women -- in the community prior to the influenza season, and follow all women for different outcomes through the influenza season. While such a study would be robust, it would be complex, involve a large sample size, and be expensive. Also, additional studies are needed to assess the association between pregnancy and severe outcomes resulting from seasonal non-pH1N1 infection, studies that adjust for relevant confounding factors, and studies conducted in low-and middle income country settings.

Our review identified important discrepancies between the results in individual-level and ecological studies. Ecological studies describe a higher risk of death and ICU admission in pregnancy-associated influenza illness. Study designs which estimate risk based on group-level data, are however prone to a number of biases [@b0095], and for this reason are generally regarded as inferior to cohort studies [@b0100]. While the strength of ecological studies is typically a large population size, the ecological studies we found were generally small with the exception of one study [@b0105]. After meta-analysis, the number of patients included in individual-level studies (n = 313,522) was greater than the number of patients from ecological studies (n = 78,896). Use of a population-wide comparator (as opposed to only pregnant women), estimation of pregnancy rates, and lack of tracking of live and still births may have led to overestimation of pregnancy on adverse influenza outcomes. However, it is possible that because the ecologic studies included community-based comparison groups, they detected a signal missed by the individual-level studies.

Strengths of this systematic review include a comprehensive search strategy, risk of bias assessment, sensitivity analyses that showed similar results, and the high proportion of studies using laboratory-confirmation to define a case. Finally, a comprehensive systematic review article has not yet been published on this topic. A review article by Meijer et al. published last year used a systematic approach to identify articles of interest [@b0110]. However, the search strategy was narrow and as such missed relevant studies by including only 32 articles on maternal morbidity in contrast to the 152 studies we identified. Furthermore, it lacked a thorough critical appraisal of the evidence and no meta-analysis was conducted. In our study, an important limitation was significant heterogeneity that could not be explained by the *a priori* defined subgroup analyses. This may point to clinical heterogeneity in terms of study population and health service resources, but also possibly to different study designs and study conduct [@b0115]. Such differences would not necessarily have been detected by differences in the scores in the NOS, as the risk of bias assessment depends on the level of details known about the included studies as well as potential subjectivity [@b0120], which we aimed to minimize by using independent assessment by two investigators. Despite the 142 individual-level studies we identified, the power to detect clinically relevant differences is still limited, resulting in wide confidence intervals, in particular for the analysis on pneumonia as an outcome. We acknowledge that not considering non-English language articles is a limitation as well as the fact that the search had been completed in spring 2014. In order to make sure that we did not miss any major new studies since, we conducted a targeted search in MEDLINE using the terms "(influenza AND pregnancy) OR (influenza AND risk)". Of 1588 newly identified studies that were screened by the first author, 53 were screened in full text, and 10 studies provided data that could be added to our meta-analyses. Adding this data did not change the summary estimates significantly (mortality OR 1.04, 95% CI 0.81--1.33 without and 1.05, 0.84--1.30 with update; for ICU admission, 0.85, 0.62--1.17 and 0.76, 0.58--1.00, respectively).

We found that pregnant women are at increased risk for hospitalization but we did not find an increase in risk of death or other severe outcomes. The higher rate of hospitalization supports vaccination for pregnant women, although whether the cause for hospitalization was due to severity of illness versus pre-emptive admission is unclear. Furthermore, influenza vaccines have been found to be safe and effective at preventing influenza virus infection in pregnant women and in their newborn children [@b0125], [@b0130]. This evidence of vaccine performance as well as the programmatic opportunities afforded vaccine delivery during routine antenatal care support public health efforts to immunize pregnant women against influenza illness [@b0135].

5. Conclusions {#s0075}
==============

We found that influenza during pregnancy resulted in a higher risk of hospitalization than in non-pregnant individuals, but that mortality following influenza was similar in pregnant and non-pregnant individuals.
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Supplementary data 1

Supplementary data associated with this article can be found, in the online version, at [http://dx.doi.org/10.1016/j.vaccine.2016.12.012](10.1016/j.vaccine.2016.12.012){#ir010}.

![Flow sheet of studies included and excluded (search update). Legend: ^\*^ "Original search" refers to the search for the systematic review conducted in 2011 [@b0015]; ^†^ One article reported on two study populations; ^‡^ One article reported ecological as well as individual-level data.](gr1){#f0005}

![Forest plot for pregancy as a risk factor for mortality following influenza. Legend: Subgroups: source of population (community-based, hospital-based, ICU-based patient population). Not estimable: each study was only included once in the forest plot with data on the largest patient population available. E.g. the study for Buda et al. was only included in the community subgroup but deemed not estimable in the hospitalized group.](gr2){#f0010}

![Forest plot for pregancy as a risk factor for hospitalization following influenza.](gr3){#f0015}

###### 

Characteristics of ecological studies (n = 10).

  Author                    Year       Region                      Time of study     Strain              Influenza laboratory confirmation   Sample size   Participants                              Comparator group                              Outcome                                                    95% confidence interval
  ------------------------- ---------- --------------------------- ----------------- ------------------- ----------------------------------- ------------- ----------------------------------------- --------------------------------------------- ---------------------------------------------------------- -------------------------
  Baigalmaa [@b0140]        2012       Mongolia                    10/2009--1/2010   pH1N1               Yes                                 29            Hospital deaths                           Nationwide prevalence data for risk factors   *Mortality*: RR 50                                         21, 118
  Campbell [@b0145]         2011       England                     4/2009--1/2010    pH1N1               Yes                                 2416          Hospitalized patients                     Women 15--44 years                            *Hospitalization*: RR 7.8                                  6.4, 9.6
  Dede [@b0150]             2011       Turkey                      10--12/2009       pH1N1               Yes                                 599           pH1N1 confirmed deaths                    Non-pregnant general population               *Mortality*: RR 3.9                                        2.8, 5.4
  Jamieson [@b0085]         2009       United States               4--5/2009         pH1N1 predominant   Yes                                 34            Pregnant women with confirmed influenza   General population                            *Hospitalization*: 0.32/100,000 versus 0.076/100,000       0.13, 0.52
  2.3, 7.8                                                                                                                                                                                                                                                                                                    
  Kelly [@b0155]            2009       Australia                   5--10/2009        pH1N1               Unclear                             4833          Pregnant women                            Non-pregnant participants                     *Hospitalization*: RR 5.2                                  4.6, 5.8
  *ICU admission:* RR 6.5   4.8, 8.8                                                                                                                                                                                                                                                                          
  *Mortality*: RR 1.4       0.4--4.5                                                                                                                                                                                                                                                                          
  Mytton [@b0160]           2012       England                     7/2009--4/2010    pH1N1               Yes (not all cases)                 361           pH1N1 confirmed deaths                    Women 16--45 years                            *Mortality (age standardized)*: 13 versus 5.1; p \< 0.01   5.7, 35
  3.8, 6.7                                                                                                                                                                                                                                                                                                    
  Pebody [@b0165]           2010       UK                          4/2009--3/2010    pH1N1               Yes (not all cases)                 308           Confirmed pH1N1 dead                      Women 15--44 years                            *Mortality*: RR 7                                          3, 15
  Seppelt [@b0170]          2010       Australia and New Zealand   6--8/2009         pH1N1               Yes                                 64            Pregnant and postpartum                   Non-pregnant women 15--44 years               *ICU admission:* RR 7.4                                    5.5, 10
  Van Kerkhove [@b0105]     2011       19 Countries                4/2009--1/2010    pH1N1               Yes                                 ∼70,000       pH1N1 confirmed in ICU                    Women 15--49 years                            *Hospitalization*: RR 6.8                                  4.5, 12.3
  *Mortality*: RR 1.9       0.0, 2.6                                                                                                                                                                                                                                                                          
  Wilking [@b0175]          2010       Germany                     4/2009--3/2010    pH1N1               Yes (not all cases)                 252           pH1N1 confirmed deaths                    Women 15--49 years                            *Mortality*: RR 2.2                                        0.5, 9.4

Legend: RR risk ratio, pH1N1 pandemic 2009 influenza A (H1N1).
